RIPK3 and melanoma: It has been shown that RIPK3-expressing melanoma cells were sensitive to necroptosis-inducing agents and cell death could be efficiently inhibited by necrostatin-1 [141], although gaining competence to trigger necroptosis upon overexpression of RIPK3 has been questioned by others [144].